专利号:US-2013035307-A1 优先权日:2010-01-26 标 题:Methods for treating or preventing the spread of cancer using semi-synthetic glycosaminoglycosan ethers 发明人:PRESTWICH GLENN D; KENNEDY THOMAS P 权利人:UNIV UTAH RES FOUND; PRESTWICH GLENN D; KENNEDY THOMAS P 摘要:Described herein are methods for the treatment and prevention of tumor metastasis using alkylated and fluoroalkylated semi-synthetic glycosaminoglycan ethers (“SAGEsâ€?). The synthesis of sulfated alkylated and fluoroalkylated SAGEs is also described.
专利号:WO-2023096715-A9 优先权日:2021-10-22 标 题:Immunomodulatory glycosphingolipids and methods of use thereof 发明人:KASPER DENNIS; OH SUNGWHAN 权利人:HARVARD COLLEGE 摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.
专利号:US-2022125838-A1 优先权日:2019-02-11 标题 :Immunomodulatory glycosphingolipids and methods of use thereof 发明人:OH SUNGWHAN; KASPER DENNIS L; SONG HEEBUM; PARK SEUNG BUM 权利人:HARVARD COLLEGE; SEOUL NAT UNIV R&DB FOUNDATION 摘要:Provided herein are a subset of alpha-galactosylceramide (alpha-GC) compounds having improved immunomodulatory activity, particularly with respect to NKT cell number and activity. Also provided herein are methods of use of such compounds, including in the modulation of NKT cells and/or activity in vivo. Further provided are combinatorial synthesis methods for generating alpha-GC compounds of specifically defined structure and thereby generating pure preparations thereof.
专利号:US-9907753-B2 优先权日:2010-03-19 标 题 :Lipid vesicle compositions and methods of use 发明人:IRVINE DARRELL J; MOON JAEHYUN 权利人:MASSACHUSETTS INST TECHNOLOGY 摘要:The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
专利号:US-2023407258-A1 优先权日:2019-09-16 标 题:Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
专利号:WO-2021055448-A1 优先权日:2019-09-16 标题:Treatment of disc degenerative disease and stimulation of proteoglycan synthesis by fibroblast conditioned media and formulations thereof
1: Carlucci G, Mazzeo P. Simultaneous determination of furprofen and rufloxacin in human plasma by high-performance liquid chromatography. J Chromatogr Sci. 1996 Apr;34(4):182-4. doi: 10.1016/j.chroma.2014.09.034. Epub 2014 Sep 22.
合成参考文献
摘要:Archives Internationales de Pharmacodynamie et de Therapie., 214(240), 1975 [] 摘要:Journal of Clinical Pharmacology., 16(473), 1976 []